SEC Form 4 research

CytomX Therapeutics, Inc. insider transactions

Recent insider disclosures

Officers and directors in the directory

• BELVIN MARCIA — 7 qualifying
• Campoy Carlos — 2 qualifying
• Canaan IX L.P. — 29 qualifying
• Canaan Partners IX LLC — 29 qualifying
• Chu Yu-Waye — 18 qualifying
• GLUCK FREDERICK W — 22 qualifying
• Goeltz II Robert C. — 20 qualifying
• HANNAH ALISON L. — 3 qualifying
• HUMPHREY RACHEL — 5 qualifying
• Jones Elaine V — 1 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.